Elevance Health, Inc. — Director's Dealing 2021

May 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-05-24

Reporting Person: Gallina John E (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-24	Common Stock	M	5775	$146.93	Acquired	60095	Direct
2021-05-24	Common Stock	M	1962	$131.80	Acquired	62057	Direct
2021-05-24	Common Stock	M	4038	$132.51	Acquired	66095	Direct
2021-05-24	Common Stock	M	19908	$166.97	Acquired	86003	Direct
2021-05-24	Common Stock	M	14761	$232.04	Acquired	100764	Direct
2021-05-24	Common Stock	S	17819	$393.56	Disposed	82945	Direct
2021-05-24	Common Stock	S	8163	$394.62	Disposed	74782	Direct
2021-05-24	Common Stock	S	15262	$395.67	Disposed	59520	Direct
2021-05-24	Common Stock	S	1100	$396.50	Disposed	58420	Direct
2021-05-24	Common Stock	S	4100	$397.91	Disposed	54320	Direct
2021-05-25	Common Stock	G	3301	—	Disposed	51019	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-24	Employee Stock Option (Right to Buy)	$146.93	M	5775	Disposed	2025-03-02	Common Stock (5775.0)	Direct
2021-05-24	Employee Stock Option (Right to Buy)	$131.8	M	1962	Disposed	2026-03-01	Common Stock (1962.0)	Direct
2021-05-24	Employee Stock Option (Right to Buy)	$132.51	M	4038	Disposed	2026-06-01	Common Stock (4038.0)	Direct
2021-05-24	Employee Stock Option (Right to Buy)	$166.97	M	19908	Disposed	2027-03-01	Common Stock (19908.0)	Direct
2021-05-24	Employee Stock Option (Right to Buy)	$232.04	M	14761	Disposed	2028-03-01	Common Stock (14761.0)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021.

F2: This transaction was executed in multiple trades at prices ranging from $393.17 to $394.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $394.18 to $395.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $395.23 to $396.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $396.23 to $396.56. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $397.50 to $398.39. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: The option represents a right to purchase a total of 5,775 shares and is exercisable in six semi-annual installments, with three installments of 962 shares each and three installments of 963 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted.

F8: The option represents a right to purchase a total of 5,883 shares and is exercisable in six semi-annual installments, with three installments of 980 shares each and three installments of 981 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted.

F9: The option represents a right to purchase a total of 8,074 shares and is exercisable in six semi-annual installments, with two installments of 1,345 shares each and four installments of 1,346 shares each beginning on December 1, 2016, which is the six-month anniversary of the date on which the option was granted.

F10: The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on September 1, 2017, which is the six-month anniversary of the date on which the option was granted.

F11: The option represents a right to purchase a total of 14,761 shares and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares beginning on September 1, 2018, which is the six-month anniversary of the date on which the option was granted.